Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Azrilevich, A."'
Autor:
Nakano, Silvia, Azrilevich, Paola A.
Publikováno v:
Nakano, Silvia and Azrilevich, Paola A. Avances en torno a la Ley Nº 26.899., 2016 . In Jornada Virtual Acceso Abierto Argentina 2016, Buenos Aires, Argentina, 25 de noviembre de 2016. (Unpublished) [Presentation]
The progress of the Regulation of Law No. 26,899 "Creation of Digital Institutional Repositories of Open Access, Own or Shared" is presented, which will regulate Open Access to the scientific-technological production of Argentina.
Externí odkaz:
http://eprints.rclis.org/30471/
Autor:
Li Wang, Abdel Saci, Peter M. Szabo, Scott D. Chasalow, Mireia Castillo-Martin, Josep Domingo-Domenech, Arlene Siefker-Radtke, Padmanee Sharma, John P. Sfakianos, Yixuan Gong, Ana Dominguez-Andres, William K. Oh, David Mulholland, Alex Azrilevich, Liangyuan Hu, Carlos Cordon-Cardo, Hélène Salmon, Nina Bhardwaj, Jun Zhu, Matthew D. Galsky
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Although T-cell infiltration is correlated with EMT-related gene expression in urothelial cancer specimens, here, the authors report EMT-related signatures in urothelial cancer arise mainly from stromal cells. Increased EMT-related gene expression in
Externí odkaz:
https://doaj.org/article/0e94d49acf9b403fa3f22b69087eb769
Autor:
Sharma, Padmanee *, Retz, Margitta, Siefker-Radtke, Arlene, Baron, Ari, Necchi, Andrea, Bedke, Jens, Plimack, Elizabeth R, Vaena, Daniel, Grimm, Marc-Oliver, Bracarda, Sergio, Arranz, José Ángel, Pal, Sumanta, Ohyama, Chikara, Saci, Abdel, Qu, Xiaotao, Lambert, Alexandre, Krishnan, Suba, Azrilevich, Alex, Galsky, Matthew D
Publikováno v:
In The Lancet Oncology March 2017 18(3):312-322
Autor:
Sharma, Padmanee, Callahan, Margaret K, Bono, Petri, Kim, Joseph, Spiliopoulou, Pavlina, Calvo, Emiliano, Pillai, Rathi N, Ott, Patrick A, de Braud, Filippo, Morse, Michael, Le, Dung T, Jaeger, Dirk, Chan, Emily, Harbison, Chris, Lin, Chen-Sheng, Tschaika, Marina, Azrilevich, Alex, Rosenberg, Jonathan E
Publikováno v:
In The Lancet Oncology November 2016 17(11):1590-1598
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maria Lia Palomba, Matthew G. Mei, Paolo F. Caimi, Matthew Cortese, Marco Davila, Greg Yadnik, Nestor Huang, David Mou, Martin Oft, Paul-Joseph Aspuria, Anita Mehta-Damani, Navneet Ratti, Naiyer Rizvi, Alex Azrilevich, Ran Reshef
Publikováno v:
Cancer Research. 83:CT125-CT125
Background: Chimeric antigen receptor T cell therapy (CAR T) has demonstrated remarkable clinical efficacy in hematological malignancies. However, compromised T cell effector function, proliferation, and persistence can limit CAR T from reaching thei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7184a437d51ba577e7b47333e1e171d3
https://doi.org/10.1158/1538-7445.am2023-ct125
https://doi.org/10.1158/1538-7445.am2023-ct125
Autor:
Persano, Humberto, Gutnisky, David, Kugler, María Victoria, Alul, María Florencia, Azrilevich, Ana, Cángaro, Eva, Iarussi, Natalia, Mosquera, Jose Ignacio, Peralba, Luciana, Gowland, Rafael Pozo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37232af62fa9b415bc2d19a61d8a22c5
Publikováno v:
Anuario de Investigaciones, Vol 18, Pp 89-94 (2011)
El siguiente trabajo se enmarca dentro de un proyecto UBACyT sobre conductas de afrontamiento en trastornos de ansiedad. En el presente artículo se muestran los resultados de una revisión bibliográica sobre la utilización de la preocupación como
Externí odkaz:
https://doaj.org/article/6fbd6424d8f742379286fe5137fa01ed
Autor:
David Spigel, Alexander Spira, Dmitriy Zamarin, David F. McDermott, Jason Luke, John V. Heymach, Rebecca Previs, Ryan Sullivan, Leena Gandhi, Alex Azrilevich, Naiyer Rizvi, Martin Oft, Natalie Busby, Benjamin Izar
Publikováno v:
Cancer Research. 82:CT244-CT244
Background: High dose intravenous (IV) interleukin-2 (IL-2) induces complete responses in certain cancers, but its use is limited due to toxicities including severe hypotension and capillary leak syndrome (CLS), and the requirement for inpatient admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::924898dd9f79839cedffc99d7c80e7de
https://doi.org/10.1158/1538-7445.am2022-ct244
https://doi.org/10.1158/1538-7445.am2022-ct244